HomeSearch by MicroorganismStaphylococcus aureus (community-acquired + methicillin-resistant)
Microorganism
MIC50
(μg/ml)
sort
MIC90
(μg/ml)
sort
Range
(μg/ml)
sort
Antimicrobial sort
Reference
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.06 0.25 0.06 - 0.25 Minocycline (Minocycline hydrochloride, Minocin) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.12 0.12 0.06 - 0.12 Clindamycin (Cleocin) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.12 0.12 0.06 - 0.12 Retapamulin 604
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.12 0.25 0.06 - 0.5 ME1036 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.125 0.03 0.015 - 0.03 BC-7013 604
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.25 0.25 0.12 - 0.25 Fusidic acid (Fucidin) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) ≤0.25 ≤0.25 ≤0.25 - ? Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.25 0.5 ≤0.12 - >4 Levofloxacin (Levaquin, Quixin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.25 0.5 0.25 - 1 Daptomycin (Cubicin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 0.5 0.5 0.25 - 1 Ceftaroline 110
Staphylococcus aureus (community-acquired + methicillin-resistant) ≤0.5 ≤0.5 ≤0.5 - >16 Tetracycline (Sumycin, Achromycin V, Steclin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 1 1 0.5 - 2 Vancomycin (Vancocyn, Lyphocin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 1 2 1 - 2 RWJ-416457 189
Staphylococcus aureus (community-acquired + methicillin-resistant) 2 2 ≤0.5 - 8 Meropenem (Merrem) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 2 2 1 - 2 Linezolid (PNU-100766, U-100766, Zyvox) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 4 4 2 - 4 Linezolid (PNU-100766, U-100766, Zyvox) 189
Staphylococcus aureus (community-acquired + methicillin-resistant) ≤4 ≤4 ≤4 - >128 Mupirocin (Bactroban) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) >8 >8 2 - >8 Amoxicillin-clavulanate 110
Staphylococcus aureus (community-acquired + methicillin-resistant) >8 >8 2 - >8 Erythromycin (E-mycin, Ery-tab, Benzamycin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) >16 >16 >16 - ? Erythromycin (E-mycin, Ery-tab, Benzamycin) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) >32 >32 16 - >32 Ceftriaxone (Rocephin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) 109 109 ≤1.7 - 129 Neomycin (Mycifradin, Neo-Fradin) 604
Staphylococcus aureus (community-acquired + methicillin-resistant) - 0.06 ? - ? BC-3205 602
Staphylococcus aureus (community-acquired + methicillin-resistant) - 0.12 ? - ? Clindamycin (Cleocin) 602
Staphylococcus aureus (community-acquired + methicillin-resistant) ≤- ≤0.25 ≤0.25 - ? Clindamycin (Cleocin) 110
Staphylococcus aureus (community-acquired + methicillin-resistant) ≤- ≤0.5 ≤0.5 - 2 Imipenem 110
Staphylococcus aureus (community-acquired + methicillin-resistant) - 0.5 ? - ? Levofloxacin (Levaquin, Quixin) 602
Staphylococcus aureus (community-acquired + methicillin-resistant) - 2 ? - ? Linezolid (PNU-100766, U-100766, Zyvox) 602